The Oncology Institute, Inc. (TOI): Price and Financial Metrics
TOI Price/Volume Stats
| Current price | $1.30 | 52-week high | $2.66 |
| Prev. close | $1.39 | 52-week low | $0.33 |
| Day low | $1.27 | Volume | 690,100 |
| Day high | $1.43 | Avg. volume | 392,033 |
| 50-day MA | $1.77 | Dividend yield | N/A |
| 200-day MA | $1.05 | Market Cap | 95.87M |
TOI Stock Price Chart Interactive Chart >
TOI POWR Grades
- TOI scores best on the Sentiment dimension, with a Sentiment rank ahead of 86.59% of US stocks.
- TOI's strongest trending metric is Momentum; it's been moving up over the last 154 days.
- TOI's current lowest rank is in the Quality metric (where it is better than 8.35% of US stocks).
TOI Stock Summary
- With a one year PEG ratio of 0.01, ONCOLOGY INSTITUTE INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 0.22% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, ONCOLOGY INSTITUTE INC is reporting a growth rate of -18,587.71%; that's higher than just 0.15% of US stocks.
- The volatility of ONCOLOGY INSTITUTE INC's share price is greater than that of 94.21% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to ONCOLOGY INSTITUTE INC are HCDI, GGE, RAND, WYNN, and XPOF.
- To check out ONCOLOGY INSTITUTE INC's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001799191.
TOI Valuation Summary
- TOI's EV/EBIT ratio is -3.9; this is 130.71% lower than that of the median Healthcare stock.
- TOI's price/sales ratio has moved down 1.4 over the prior 45 months.
Below are key valuation metrics over time for TOI.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| TOI | 2023-11-20 | 0.5 | 2.3 | -2.2 | -3.9 |
| TOI | 2023-11-17 | 0.5 | 2.4 | -2.3 | -4.0 |
| TOI | 2023-11-16 | 0.5 | 2.1 | -2.0 | -3.7 |
| TOI | 2023-11-15 | 0.5 | 2.3 | -2.2 | -3.9 |
| TOI | 2023-11-14 | 0.6 | 2.5 | -2.4 | -4.1 |
| TOI | 2023-11-13 | 0.6 | 2.6 | -2.5 | -4.3 |
The Oncology Institute, Inc. (TOI) Company Bio
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and 24/7 patient support. The company was founded in 2007 and is headquartered in Cerritos, California.
Latest TOI News From Around the Web
Below are the latest news stories about ONCOLOGY INSTITUTE INC that investors may wish to consider to help them evaluate TOI as an investment opportunity.
The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in CaliforniaCERRITOS, Calif, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (TOI) announced today that it has started operations of its first pharmacy in California after receiving approval from the California State Board of Pharmacy. This new service allows TOI to fill not only critical specialty medications and chemotherapeutics for MediCal patients, but also to provide medication fill capabilities to other patient populations. Located in the Los Angeles area, this new pharmacy location co |
Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI)In a notable insider transaction, Director Brad Hively has parted with 47,000 shares of The Oncology Institute Inc (NASDAQ:TOI), a significant move that warrants a closer look by investors and market analysts. |
Even With A 49% Surge, Cautious Investors Are Not Rewarding The Oncology Institute, Inc.'s (NASDAQ:TOI) Performance CompletelyDespite an already strong run, The Oncology Institute, Inc. ( NASDAQ:TOI ) shares have been powering on, with a gain of... |
The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss WidensTOI Reaffirms Full Year 2023 Guidance Amidst Expansion and Operational Developments |
The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 GuidanceCERRITOS, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and nine months ended September 30, 2023 and reaffirmed its full year 2023 guidance. Recent Operational Highlights: Opened our 70th clinic and added 5 physicians bringing our total provider count to 112We are live on Ambience, a tool that utilizes AI te |
TOI Price Returns
| 1-mo | -29.35% |
| 3-mo | 2.36% |
| 6-mo | 109.68% |
| 1-year | 13.04% |
| 3-year | -87.48% |
| 5-year | N/A |
| YTD | -21.21% |
| 2022 | -83.08% |
| 2021 | -9.72% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...